國家衛生研究院 NHRI:Item 3990099045/1160
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 916392      線上人數 : 1437
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/1160


    題名: Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
    作者: Chen, CN;Lin, CPC;Huang, KK;Chen, WC;Hsieh, HP;Liang, PH;Hsu, JTA
    貢獻者: Division of Biotechnology and Pharmaceutical Research
    摘要: SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CL(Pro)) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product library consisting of 720 compounds for inhibitory activity against 3CLPro. Two compounds in the library were found to be inhibitive: tannic acid (IC50 = 3 mu M) and 3-isotheaflavin-3-gallate (TF2B) (IC50 = 7 mu M). These two compounds belong to a group of natural polyphenols found in tea. We further investigated the 3CL(Pro)-inhibitory activity of extracts from several different types of teas, including green tea, oolong tea, Puer tea and black tea. Our results indicated that extracts from Puer and black tea were more potent than that from green or oolong teas in their inhibitory activities against 3CLPro. Several other known compositions in teas were also evaluated for their activities in inhibiting 3CLPro. We found that caffeine, (-)-epigallocatechin gallte (EGCg), epicatechin (EC), theophylline (TP), catechin (C), epicatechin gallate (ECg) and epigallocatechin (EGC) did not inhibit 3CLPro activity. Only theaflavin-3,3'-digallate (TF3) was found to be a 3CLPro inhibitor. This study has resulted in the identification of new compounds that are effective 3CLPro inhibitors.
    關鍵詞: Integrative & Complementary Medicine
    日期: 2005
    關聯: Evidence-based Complementary and Alternative Medicine. 2005;2:209-215.
    Link to: http://dx.doi.org/10.1093/ecam/neh081
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000232027400012
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=24344464802
    顯示於類別:[徐祖安] 期刊論文
    [謝興邦] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    000232027400012.pdf128KbAdobe PDF408檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋